ArTS Archivio della ricerca di Trieste

FABRIS, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.662
EU - Europa 3.308
AS - Asia 2.071
SA - Sud America 58
OC - Oceania 26
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 12.156
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.617
IT - Italia 1.141
SE - Svezia 700
CN - Cina 656
SG - Singapore 632
HK - Hong Kong 444
DE - Germania 280
BG - Bulgaria 200
IE - Irlanda 168
UA - Ucraina 151
GB - Regno Unito 119
PL - Polonia 116
FI - Finlandia 103
TR - Turchia 100
CH - Svizzera 66
RU - Federazione Russa 64
IN - India 60
JP - Giappone 51
FR - Francia 48
NL - Olanda 34
BR - Brasile 31
VN - Vietnam 30
CA - Canada 27
ES - Italia 27
IR - Iran 25
KR - Corea 24
AU - Australia 23
BE - Belgio 22
SN - Senegal 17
AT - Austria 15
RO - Romania 15
MX - Messico 14
ID - Indonesia 12
AR - Argentina 10
DK - Danimarca 10
EU - Europa 9
CZ - Repubblica Ceca 8
CO - Colombia 6
KZ - Kazakistan 6
MY - Malesia 6
PE - Perù 6
GR - Grecia 5
PK - Pakistan 5
SV - El Salvador 4
TH - Thailandia 4
TW - Taiwan 4
EC - Ecuador 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
EG - Egitto 2
PH - Filippine 2
RS - Serbia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
SA - Arabia Saudita 1
SI - Slovenia 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 12.156
Salva come PNG Salva come JPEG
Città #
Fairfield 909
Chandler 668
Woodbridge 627
Ashburn 574
Singapore 528
Wilmington 461
Houston 429
Hong Kong 426
Seattle 426
Ann Arbor 408
Cambridge 291
Princeton 259
Trieste 226
Jacksonville 220
Beijing 212
Sofia 200
Dublin 163
Warsaw 110
Santa Clara 100
Izmir 71
Boardman 66
Milan 64
Dearborn 63
Rome 59
Helsinki 58
San Diego 58
Venezia 50
Bern 48
Grafing 38
Redwood City 34
Rostock 30
Shanghai 27
Turin 27
Dong Ket 26
Washington 25
Jinan 22
Des Moines 20
Los Angeles 20
Tokyo 20
Brussels 19
Bremen 18
Guangzhou 18
London 18
Toronto 18
Dakar 17
Nanjing 16
Naples 16
Redmond 16
Brescia 15
Monfalcone 15
Pune 15
Falls Church 14
Lappeenranta 14
Bari 13
Dallas 13
Falkirk 13
Mumbai 13
Nuremberg 12
Seoul 12
Vienna 12
Bologna 11
Madrid 11
Wuhan 11
Andover 10
Chicago 10
Frankfurt am Main 10
Hefei 10
Mykolayiv 10
Padova 10
Palermo 10
Portici 10
Shenyang 10
São Paulo 10
Valenzano 10
Aarhus 9
Kocaeli 9
Kunming 9
Norwalk 9
Udine 9
Cagliari 8
Catania 8
Florence 8
New York 8
Sydney 8
Timisoara 8
Amsterdam 7
Asheville 7
Perth 7
San Mateo 7
Zhengzhou 7
Dongguan 6
Duncan 6
Geneva 6
Genoa 6
Hangzhou 6
Hebei 6
Kurchatov 6
Lima 6
Lucca 6
Menlo Park 6
Totale 8.711
Salva come PNG Salva come JPEG
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 382
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 303
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 243
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial 236
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 211
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 210
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 205
Treatment of Functional Mitral Regurgitation in Heart Failure 204
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 190
Coronary covered stents 190
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 182
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? 174
The role of clinical observation: Red flag 5-right ventricular involvement, arrhythmogenic right ventricular cardiomyopathy and associated phenotypes 174
The role of clinical observation: Red flag 1-cardiomyopathies and skeletal muscle involvement 170
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 164
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 160
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 157
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 156
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 156
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 155
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 150
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 150
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 148
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 148
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program 145
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 145
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 139
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study 138
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts 137
The role of clinical observation: red flag 8 - Cardiomyopathies in the first year of life and pediatric cardiomyopathies. 135
null 135
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 134
null 131
Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention 123
Impact of patient delay in a modern real world STEMI network 123
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. 122
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 122
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 118
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 116
The evolution of cardiology: Changes, future challenges and opportunities 114
Nonatherosclerotic Coronary Artery Narrowing 113
If heart failure or cardiac arrest complicate pregnancy and delivery 111
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 111
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity 109
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT) 109
null 108
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres 108
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 106
Direct cellular reprogramming: the hopes and the hurdles 105
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 105
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? 103
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy 102
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 97
La cardiomiopatia dilatativa non sempre è evolutiva: come evitare decisioni errate? 91
Guide extension, unmissable tool in the armamentarium of modern interventional cardiology. A comprehensive review 90
Clinical Spectrum of PRKAG2 Syndrome 90
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection 90
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 89
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 88
Natural history of spontaneous coronary dissections 85
Insufficienza tricuspidale e indicazioni al trattamento 85
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 84
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS 82
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 80
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 69
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 66
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention 63
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 63
Supraventricular Tachycardia Causing Left Ventricular Dysfunction 63
Effect of prehospital treatment in STEMI patients undergoing primary PCI 63
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut TAVR 62
Pathogenesis 61
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction 60
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: Insights from the ATLANTIC trial 59
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery 59
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction 59
IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry 58
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 58
Thoracic pain: Clinical features 58
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 56
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study 55
Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation 54
Rimodellamento inverso nei pazienti con disfunzione ventricolare sinistra: predittori di miglioramento e revisione della letteratura 54
Near-infrared spectroscopy-intravascular ultrasound: Scientific basis and clinical applications 53
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice 53
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 52
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial 50
Angiography and electrocardiography (ECG) for the assessment of coronary microvascular obstruction 50
Antithrombotic therapy in heart failure and sinus rhythm: the ongoing search for a better match of patients to therapy 50
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC Trial 49
Influence of multimodality coronary imaging on revascularization strategy 48
Renin-angiotensin system inhibitors and mortality among diabetic patients with STEMI undergoing mechanical reperfusion during the COVID-19 pandemic 47
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 47
A 20-year experience in cardiac tumors: a single center surgical experience and a review of literature 46
Appropriateness and surroundings: "Doing more does not mean doing better". Choosing wisely, an unfulfilled commitment? 46
Fractional Flow Reserve–Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus 46
Resolute zotarolimus-eluting stent in ST-elevation myocardial infarction (resolute-STEMI): A prespecified prospective register from the DAPT-STEMI trial 45
Cardiac amyloidosis: do not forget to look for it 45
Entrapment of dissection flap and intimal tissue cleavage during rotational atherectomy 45
Rimodellamento inverso nella disfunzione ventricolare sinistra: evidenze e prospettive 44
Totale 10.992
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.784
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.690 0 0 0 226 91 198 179 173 203 386 139 95
2020/20212.358 95 123 135 532 303 224 228 121 101 194 109 193
2021/20221.650 69 104 64 70 122 153 76 65 227 142 160 398
2022/20232.229 216 295 256 264 163 387 40 141 257 38 128 44
2023/20242.039 106 95 76 119 147 231 292 390 29 112 222 220
2024/20251.267 189 428 535 115 0 0 0 0 0 0 0 0
Totale 12.822